Home › Psoriasis › California › Fremont
Psoriasis clinical trials in Fremont, CA
5 studies for Psoriasis are looking for participants at sites in and around Fremont (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RecruitingPhase 4
- Center For Dermatology Clinical Research, Inc., Fremont
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
RecruitingPhase 3
- Center For Dermatology Clinical Research, Inc., Fremont
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
RecruitingPhase 3
- Vanda Investigational Site, Fremont
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
RecruitingPhase 3
- Ppp001 50176, Fremont
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
RecruitingPhase 2
- Study Center, Fremont
About Psoriasis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Some people also get psoriasis arthritis.
More about Psoriasis on MedlinePlus
Psoriasis trials in other cities
- Trenton, NJ7 studies
- Philadelphia, PA6 studies
- Cleveland, OH6 studies
- Huntington Beach, CA5 studies
- San Antonio, TX5 studies
- New York City, NY5 studies
- Newton, MA5 studies
- Houston, TX4 studies
- Birmingham, AL4 studies
- Sacramento, CA3 studies
- Miami, FL3 studies
- Indianapolis, IN3 studies
Other studies in Fremont
- Lung Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Breast Cancer5 studies
- Prostate Cancer5 studies
- Atopic Dermatitis (Eczema)4 studies
- Ovarian Cancer3 studies
- Atrial Fibrillation3 studies
- Blood Clots3 studies
- Chronic Kidney Disease3 studies
- Pancreatic Cancer3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.